Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
| Actual shortage: | 251 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-DILTIAZEM XC | 240MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2024-01-11 | 2024-04-25 | 215740 |
| TEVA-DUTASTERIDE | 0.5MG | CAPSULE | Actual shortage | 2023-02-09 | 2024-04-25 | 184216 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Actual shortage | 2023-07-27 | 2024-04-25 | 200307 |
| TEVA-VORICONAZOLE | 50MG | TABLET | Actual shortage | 2023-10-19 | 2024-04-25 | 207545 |
| TEVA-ROPINIROLE | 0.25MG | TABLET | Actual shortage | 2024-02-08 | 2024-04-25 | 218977 |
| TEVA-FLUVASTATIN | 40MG | CAPSULE | Actual shortage | 2024-02-29 | 2024-04-25 | 220983 |
| TEVA-FENTANYL | 100MCG | PATCH | Actual shortage | 2024-01-25 | 2024-04-25 | 217223 |
| TEVA-FENTANYL | 50MCG | PATCH | Actual shortage | 2024-02-01 | 2024-04-25 | 218137 |
| TEVA-FENTANYL | 25MCG | PATCH | Actual shortage | 2024-02-01 | 2024-04-25 | 218132 |
| TEVA-SIMVASTATIN | 20MG | TABLET | Actual shortage | 2023-07-11 | 2024-04-25 | 198306 |
| TEVA-SIMVASTATIN | 20MG | TABLET | Actual shortage | 2023-07-11 | 2024-04-25 | 198309 |
| TEVA-SIMVASTATIN | 5MG | TABLET | Actual shortage | 2023-08-17 | 2024-04-25 | 202252 |
| TEVA-TOPIRAMATE | 25MG | TABLET | Actual shortage | 2024-04-11 | 2024-04-25 | 224889 |
| TEVA-SUCRALFATE | 1G | TABLET | Actual shortage | 2024-03-07 | 2024-04-25 | 221540 |
| TEVA-DOMPERIDONE | 10MG | TABLET | Actual shortage | 2024-02-29 | 2024-04-25 | 220980 |
| TEVA-LENOLTEC NO. 3 | 300MG 30MG 15MG | TABLET | Actual shortage | 2024-04-18 | 2024-04-25 | 225477 |
| ACT ENALAPRIL | 8MG | TABLET | Actual shortage | 2024-04-18 | 2024-04-18 | 225486 |
| TEVA-TOPISONE | 0.05% | LOTION | Actual shortage | 2024-04-18 | 2024-04-18 | 225480 |
| TEVA-TADALAFIL | 20MG | TABLET | Resolved | 2023-12-07 | 2024-04-18 | 212725 |
| ACT QUETIAPINE | 100MG | TABLET | Resolved | 2024-02-08 | 2024-04-18 | 218974 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64606 |
| TEVA-ATORVASTATIN | 10MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64601 |
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |
| TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
| ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
| ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |